Article image
Article image
Article image
Article image

TUBERCULOSIS.

M. SPAHLINGER S SERUM. 1 THE LANCET UNIMPRESSED. Drees Association—By Telegraph—Copyright LONDON, December 16. The Lancet, in discussing the appeal on behalf of M. Spahlinger and the optimistic reports of his treatment, says; “New cures and fresh treatment of disease are sometimes received by the daily press and the public with unguarded enthusiasm, which bequeaths a legacy of disappointment to sufferers. The great expectations of .pathology are not always realised. Even those prospective remedies of which high hopes have Justly _ been formed may require a protracted period of proof or preparation before they become available to the ordinary patient. The Spahlinger treatment seems to be passing through such a stage.” After detailing the fruitless negotiations between M. Spahlinger and the Ministry of Health, and also the Red Cross, the Lancet asks: “Has M. lingor vet produced an agent enabling us to tell’the patient that the payment of a definite sura would produce a definite benefit? Until any therapeutic agent haa reached such a stage we are sorely not justified in promoting research on its behalf by appealing to the hopes and fears of patients seeking relief.’’—Sydney Sun, Gable. .

This article text was automatically generated and may include errors. View the full page to see article in its original form.
Permanent link to this item

https://paperspast.natlib.govt.nz/newspapers/ODT19231218.2.68

Bibliographic details

Otago Daily Times, Issue 19047, 18 December 1923, Page 7

Word Count
189

TUBERCULOSIS. Otago Daily Times, Issue 19047, 18 December 1923, Page 7

TUBERCULOSIS. Otago Daily Times, Issue 19047, 18 December 1923, Page 7